Cognitive and Global Morphometry Trajectories as Predictors of Youth Persistent Distressing Psychotic-Like Experiences
- PMID: 40917767
- PMCID: PMC12411066
- DOI: 10.1038/s44220-025-00481-9
Cognitive and Global Morphometry Trajectories as Predictors of Youth Persistent Distressing Psychotic-Like Experiences
Abstract
Psychotic-like experiences (PLEs) may arise from genetic and environmental risk leading to worsening cognitive and morphometry metrics over time, which in turn lead to worsening PLEs. Analyses used three waves of unique longitudinal Adolescent Brain Cognitive Development Study data (ages 9-13) to test whether changes in cognition and global morphometry metrics attenuate associations between genetic and environmental risk with persistent distressing PLEs. Multigroup univariate latent growth models examined three waves of cognitive metrics and global morphometry separately for three PLE groups: persistent distressing PLEs (n=356), transient distressing PLEs (n=408), and low-level PLEs (n=7901). Persistent distressing PLEs showed greater decreases (i.e., more negative slopes) of cognition and morphometry metrics over time compared to those in low-level PLE groups. Analyses also provided novel evidence for extant theories that worsening cognition and global morphometry metrics may partially account for associations between environmental risk with persistent distressing PLEs.
Keywords: Adolescent Brain Cognitive Development Study; adolescence; environment; genetic liability; psychotic-like experiences; trajectories.
Conflict of interest statement
Competing Interests The authors do not report any competing interests.
Figures


References
-
- Poulton R et al. Children’s Self-Reported Psychotic Symptoms and Adult Schizophreniform Disorder: A 15-Year Longitudinal Study. Arch Gen Psychiatry 57, 1053–1058 (2000). - PubMed
-
- Zammit S et al. Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. American Journal of Psychiatry 170, 742–750 (2013). - PubMed
Grants and funding
- U24 DA041147/DA/NIDA NIH HHS/United States
- U01 DA041120/DA/NIDA NIH HHS/United States
- K23 MH121792/MH/NIMH NIH HHS/United States
- R01 DA054750/DA/NIDA NIH HHS/United States
- U01 DA041093/DA/NIDA NIH HHS/United States
- R01 DA054869/DA/NIDA NIH HHS/United States
- U24 DA041123/DA/NIDA NIH HHS/United States
- U01 DA041156/DA/NIDA NIH HHS/United States
- K01 DA051759/DA/NIDA NIH HHS/United States
- U01 DA041025/DA/NIDA NIH HHS/United States
- U01 DA041089/DA/NIDA NIH HHS/United States
- U01 DA041106/DA/NIDA NIH HHS/United States
- U01 DA041117/DA/NIDA NIH HHS/United States
- U01 DA041148/DA/NIDA NIH HHS/United States
- R01 MH139880/MH/NIMH NIH HHS/United States
- U01 DA041174/DA/NIDA NIH HHS/United States
- U01 DA051038/DA/NIDA NIH HHS/United States
- F31 AA029934/AA/NIAAA NIH HHS/United States
- U01 DA041134/DA/NIDA NIH HHS/United States
- U01 DA041022/DA/NIDA NIH HHS/United States
- U01 DA041028/DA/NIDA NIH HHS/United States
- U01 DA041048/DA/NIDA NIH HHS/United States